


GentaGel-LR Email Formats
Biotechnology Research • • 1-10 Employees
GentaGel-LR Email Formats
GentaGel-LR uses 1 email format. The most common is {first initial} (e.g., j@gentagel-lr.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial} | j@gentagel-lr.com | 100% |
Key Contact at GentaGel-LR
Ariel Orbach
Chief Executive Officer
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Keywords | Injectable |
| Founded | 2021 |
| Employees | 1-10 |
About GentaGel-LR
GentaGel-LR was founded in late 2021 by Dr. Ariel Orbach, Mr. Eli Lerner, and Professor Abraham J. Domb. The company is based on a ground-breaking drug delivery technology invented by Prof. Domb, for the in-situ sustained release of antibiotics for the treatment and prevention of surgical site infections. GentaGel offers a local slow-release antibiotic treatment which is injected and continuously releases antibiotics (e.g., Gentamicin) for up to 60 days. The antibiotic is not detectable in circulation but achieves sufficient therapeutic concentrations in the administered area. Thus, GentaGel provides an effective antibiotic treatment while avoiding systemic side-effects and expensive cost-of-care. The Company is entering the clinical stage with a FIH Study to be conducted at the Sheba Medical Center, Israel.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
GentaGel-LR has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
GentaGel-LR has never raised funding before.
GentaGel-LR Tech Stack
Discover the technologies and tools that power GentaGel-LR's digital infrastructure, from frameworks to analytics platforms.
Accessibility
Hosting
Security
JavaScript libraries
Databases
Tag managers
Reverse proxies
Programming languages
Miscellaneous
Blogs
JavaScript libraries
Analytics
Frequently asked questions
4.8
40,000 users



